Erik Emerson

Mr. Erik Emerson is a Chief Executive Officer & Director at GlucoTrack, Inc. and a Chief Executive Officer & Director at Lokahi Therapeutics, Inc. He is on the Board of Directors at GlucoTrack, Inc. and Lokahi Therapeutics, Inc. Mr. Emerson was previously employed as a President & Director by Apimeds Pharmaceuticals US, Inc., a Chief Commercial Officer by Odyssey Health, Inc., a Chief Commercial Officer by Mezzion Pharmaceuticals, Inc., a President & Chief Executive Officer by Symplmed Pharmaceuticals LLC, a Senior Director-Commercial Development by XOMA Corp., and a Marketing Director by Gilead Sciences, Inc. He also served on the board at Adhera Therapeutics, Inc. He received his undergraduate degree from the University of Oregon.